|
Ryoko Sakai
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Position |
|
| Article types | Original article |
| Language | English |
| Peer review | Peer reviewed |
| Title | Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factors. |
| Journal | Formal name：Modern rheumatology Abbreviation：Mod Rheumatol ISSN code：(1439-7609)1439-7595(Linking) |
| Domestic / Foregin | Foregin |
| Volume, Issue, Page | 22(6),pp.849-58 |
| Author and coauthor | Tanaka Michi, Sakai Ryoko, Koike Ryuji, Komano Yukiko, Nanki Toshihiro, Sakai Fumikazu, Sugiyama Haruhito, Matsushima Hidekazu, Kojima Toshihisa, Ohta Shuji, Ishibe Yoji, Sawabe Takuya, Ota Yasuhiro, Ohishi Kazuhisa, Miyazato Hajime, Nonomura Yoshinori, Saito Kazuyoshi, Tanaka Yoshiya, Nagasawa Hayato, Takeuchi Tsutomu, Nakajima Ayako, Ohtsubo Hideo, Onishi Makoto, Goto Yoshinori, Dobashi Hiroaki, Miyasaka Nobuyuki, Harigai Masayoshi |
| Publication date | 2012/11 |
| Summary | Physicians must consider the possibility of PCP developing during etanercept therapy in RA patients, particularly if one or more risk factors are present. |
| DOI | 10.1007/s10165-012-0615-z |
| PMID | 22354637 |